GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JFL Life Sciences Ltd (NSE:JFLLIFE) » Definitions » Cyclically Adjusted PB Ratio

JFL Life Sciences (NSE:JFLLIFE) Cyclically Adjusted PB Ratio : (As of Jun. 04, 2025)


View and export this data going back to 2022. Start your Free Trial

What is JFL Life Sciences Cyclically Adjusted PB Ratio?

JFL Life Sciences does not have a history long enough to calculate Cyclically Adjusted Book per Share. Therefore GuruFocus does not calculate Cyclically Adjusted PB Ratio for this company.

Shiller PE for Stocks: The True Measure of Stock Valuation


JFL Life Sciences Cyclically Adjusted PB Ratio Historical Data

The historical data trend for JFL Life Sciences's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JFL Life Sciences Cyclically Adjusted PB Ratio Chart

JFL Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial - - - - -

JFL Life Sciences Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial - - - - -

Competitive Comparison of JFL Life Sciences's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, JFL Life Sciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JFL Life Sciences's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JFL Life Sciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where JFL Life Sciences's Cyclically Adjusted PB Ratio falls into.


;
;

JFL Life Sciences Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

JFL Life Sciences does not have a history long enough to calculate Cyclically Adjusted Book per Share. Therefore GuruFocus does not calculate Cyclically Adjusted PB Ratio for this company.


JFL Life Sciences  (NSE:JFLLIFE) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


JFL Life Sciences Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of JFL Life Sciences's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


JFL Life Sciences Business Description

Traded in Other Exchanges
N/A
Address
Jodhpur Cross Road, 309, Satyam Mall, Opposite Saman Complex, Near Vishweshwar Mahadev Mandir, Settelite, Ahmedabad, GJ, IND, 380015
JFL Life Sciences Ltd is engaged in the business of manufacturing pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets and Capsules (B-Lactam) solid oral dosage forms, and general tablets and capsules. Its operating segment comprises of manufacturing and selling of pharmaceutical products. Geographically, the company sells its products both in India and outside India.

JFL Life Sciences Headlines

No Headlines